Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
This study has been completed.
Study NCT01174004   Information provided by ACADIA Pharmaceuticals Inc.

First Received on July 30, 2010.   Last Updated on December 3, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Parkinson's Disease Psychosis
Additional conditions recognized in this trial
Mental Disorders
Parkinson Disease
Psychotic Disorders
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
pimavanserin tartrate
placebo
Sponsors listed in this trial
ACADIA Pharmaceuticals Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services